EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Chief Executive Officer Greg Hamilton Resigns 12.04.2023 / 20:05 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns Berlin (Germany), April 12, 2023 – The Chief Executive Officer of Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; […]
Year: 2023
20. March 2023
Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act
Ad-hoc | 20 März 2023 20:19 Epigenomics AG / Key word(s): Change in Forecast/Miscellaneous Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act 20-March-2023 / 20:19 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by […]
20. March 2023
Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act
Epigenomics AG / Key word(s): Change in Forecast/MiscellaneousEpigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act 20-March-2023 / 20:19 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group […]
10. March 2023
Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations)
EQS-News: Epigenomics AG / Key word(s): Miscellaneous/Restructure of CompanyEpigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations) 10.03.2023 / 09:37 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with […]
15. February 2023
Epigenomics resolves on restructuring to minimize costs
Epigenomics AG / Key word(s): Restructure of Company/Financing Epigenomics resolves on restructuring to minimize costs 15-Feb-2023 / 11:13 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG. The issuer is solely responsible for the content of […]
15. February 2023
Epigenomics resolves on restructuring to minimize costs
Epigenomics AG / Key word(s): Restructure of Company/FinancingEpigenomics resolves on restructuring to minimize costs 15-Feb-2023 / 11:13 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Epigenomics […]